Statements (46)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Oncology
|
| gptkbp:affects |
breast tissue
|
| gptkbp:condition |
metastasis
lymphedema |
| gptkbp:diagnosis |
biopsy
depends on stage mammography depends on grade depends on hormone receptor status depends on HER2 status |
| https://www.w3.org/2000/01/rdf-schema#label |
invasive ductal carcinoma
|
| gptkbp:is_a |
gptkb:Oncology
|
| gptkbp:number_of_stages |
Stage 0
Stage I Stage II Stage III Stage IV |
| gptkbp:prevalence |
most common type of breast cancer
|
| gptkbp:research_focus |
gptkb:immunotherapy
biomarkers personalized medicine targeted therapies |
| gptkbp:risk_factor |
age
alcohol consumption obesity family history genetic mutations |
| gptkbp:screenings |
annual mammograms after age 40
|
| gptkbp:symptoms |
lump in the breast
nipple discharge change in breast shape |
| gptkbp:treatment |
gptkb:surgery
radiation therapy chemotherapy hormone therapy hormone receptor positive has better prognosis recurrence risk varies by subtype response to chemotherapy varies by subtype survival rate varies by stage HER2 positive may respond to targeted therapy |
| gptkbp:type_of |
luminal A
luminal B triple-negative HER2-enriched |
| gptkbp:bfsParent |
gptkb:HER2-negative_breast_cancer
|
| gptkbp:bfsLayer |
6
|